Article
Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal
18 Sept 2014
Abstract excerpt
The small number of hematopoietic stem and progenitor cells in cord blood units limits their widespread use in human transplant protocols. We identified a family of chemically related small molecules that stimulates the expansion ex vivo of human cord blood cells capable of reconstituting human hematopoiesis for at least 6 months in immunocompromised mice. The potent activity of these newly identified compounds,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
